#DrugMonitoring
🧪 #Paper: “Smartphone Biosensors for Non-Invasive Drug Monitoring in Saliva.”

🔗 www.mdpi.com/2079-6374/15...

#Biosensors #DrugMonitoring #Pharmasky #SmartHealth
www.mdpi.com
April 7, 2025 at 10:40 AM
Before starting amiodarone, get baseline CXR/PFT, AST/ALT, TSH, and ECG to monitor for pulmonary, hepatic, thyroid, and QT prolongation risks. #USMLE #Amiodarone #DrugMonitoring
July 22, 2026 at 2:01 PM
Alexis Goosdeel on the evolution of harm reduction & EUDA’s new mission to tackle today’s drug challenges.

Access the Special Collection: 👉 buff.ly/yXnGbp1

#HarmReduction #DrugMonitoring
October 13, 2025 at 11:03 AM
A study used weak supervision to label over 92,000 tweets on ecstasy, GHB and 2C‑B, and an XGBoost model achieved an F1 score of 0.885 and AUPRC of 0.934. Read more: https://getnews.me/weak-supervision-detects-recreational-drug-effects-on-twitter/ #weaksupervision #drugmonitoring #publichealth
September 22, 2025 at 4:52 AM
This week, we are supporting Diabetes Awareness Week 2026. Visit our site here: lnkd.in/e3wZeK7d to explore how MedicinesComplete can support clear, consistent, and evidence-based monitoring at every stage of care.

#MedicinesComplete #DiabetesAwarenessWeek #Diabetes #Webinar #DrugMonitoring
June 11, 2026 at 10:07 AM
bi-journal.com
June 23, 2026 at 9:54 AM
🧠 Pharmacovigilance Market to reach $17.95B by 2034, growing at 8.62% CAGR. Strengthening drug safety & regulatory compliance. #PharmaSafety #DrugMonitoring 👉 www.einpresswire.com/article/7880...
Pharmacovigilance Market Expected to Achieve a Strong 8.62% CAGR, to Reach USD 17.95 Billion by 2034
The pharmacovigilance market is experiencing significant growth due to several key factors.
www.einpresswire.com
October 30, 2025 at 11:59 AM